Net Loss per Share Attributable to Common Stockholders - Potentially Dilutive Securities Outstanding (Details) - shares |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Total shares (in shares) | 3,838,748 | 3,916,684 |
| Options to purchase common stock | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Total shares (in shares) | 2,598,776 | 2,368,208 |
| Unvested RSUs | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Total shares (in shares) | 1,177,836 | 1,480,338 |
| Shares committed under ESPP | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Total shares (in shares) | 62,136 | 68,138 |